SK Bioscience Bolsters Strategic Partnership with Novavax through Equity Investment

SK Bioscience announced to make an equity investment in Novavax to address endemic challenges.

SK bioscience and Novavax have prolonged their existing licence agreement to include Novavax's newly developed COVID-19 vaccine, designed for annual immunisation. This extended partnership also involves SK bioscience's exploration of future collaborations with Novavax, which will encompass leveraging Novavax's adjuvant, known as 'Matrix-M.'

The extended licence agreement will empower SK bioscience to set up a proactive response system within South Korea's vaccination landscape for the new endemic phase. This agreement is built on a successful partnership that has spanned multiple years, allowing both companies to understand each other's strengths.

As part of the agreement, SK bioscience secures exclusive distribution rights for Novavax's COVID-19 variant vaccine in South Korea, while also gaining non-exclusive distribution rights in Thailand and Vietnam for supply and commercialisation of the vaccine.

The strategic equity investment, combined with the collaboration between SK bioscience and Novavax throughout the pandemic, will create powerful synergy.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!